Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 21 clinical trials
Featured trial
Adolescents with ADHD and a Parent with Bipolar Disorder

Adolescents with ADHD and a Parent with Bipolar Disorder

  • 253 views
  • 23 Nov, 2020
  • 1 location
Featured trial
Adolescents with Attention Deficit Hyperactivity Disorder (ADHD)

Adolescents with Attention Deficit Hyperactivity Disorder (ADHD)

  • 271 views
  • 23 Nov, 2020
  • 1 location
[C-11]NPA PET-amphetamine in Cocaine Use Disorders

This study uses [11C]NPA positron emission tomography (PET) and a d-amphetamine challenge to image amphetamine induced dopamine release in the striatum in subjects with cocaine use disorders

  • 0 views
  • 08 Jul, 2022
  • 1 location
Psilocybin-Enhanced Psychotherapy for Methamphetamine Use Disorder

This is a proof-of-concept randomized clinical trial of psilocybin-enhanced psychotherapy versus treatment-as-usual among individuals being treated for methamphetamine use disorder.

  • 0 views
  • 04 Oct, 2022
  • 1 location
Effects of MDMA-like Substances in Healthy Subjects

The serotonin (5-HT) and oxytocin releaser and so-called "empathogen" 3,4-methylenedioxymethamphetamine (MDMA) acutely produces positive feelings, empathy, and trust. MDMA is used recreationally (ecstasy), as research tool to study 5-HT and oxytocin function, and is investigated for MDMA-assisted psychotherapy. MDMA is metabolized in part (10%) to the psychoactive metabolite 3,4-methylenedioxyamphetamine (MDA) …

Accepts healthy volunteers
  • 50 views
  • 05 Jan, 2022
  • 1 location
Intermittent Oral Naltrexone Enhanced With an Ecological Momentary Intervention for Methamphetamine-using MSM

This is a double-blind, placebo-controlled phase 2b trial in which 54 MSM who use meth will be randomly assigned (2:1) to receive 12 weeks of as-needed intermittent oral naltrexone 50 mg enhanced with an EMA-informed EMI platform, or receive as-needed placebo with EMA-informed EMI. The 12-week treatment period is consistent …

Accepts healthy volunteers
  • 0 views
  • 07 Oct, 2022
  • 1 location
Effects of Genotype on Resting State Connectivity During Methamphetamine Administration (MATAAR)

Addiction to methamphetamine (MA) is a serious health problem in the United States. Right now, there are no medically approved treatments for MA dependence. More research is needed to understand how MA affects the brain and to eventually develop medical interventions for MA addiction. The purpose of the study is …

Accepts healthy volunteers
  • 0 views
  • 12 Oct, 2022
  • 2 locations
EA for PAAS: A pRCT

In 2019, around 27 million people worldwide, corresponding to 0.5% of the adult population, have used amphetamine-type stimulants (ATS). More than one-third of these 27 million users of ATS were

anxiety
opioid
psychostimulant
detoxification
opioid use
  • 9 views
  • 15 Jun, 2021
  • 1 location
Repetitive Transcranial Magnetic Stimulation in Amphetamine Addiction

The study aims to test whether transcranial magnetic stimulation (TMS) improves the craving, depression, anxiety and cognitive function during the abstinent period of methamphetamine users.

anxiety
addiction
  • 0 views
  • 05 Apr, 2022
  • 1 location
Dextromethorphan Memantine Monotherapy or Combined Use of Dextromethorphan and Memantine in Amphetamine Addiction

dextromethorphan and memantine combination (DM+MM) in amphetamine-type stimulants use disorder patients.

  • 18 views
  • 26 Jan, 2021
  • 1 location